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Community-based recruitment
of patients with COPD
into clinical research
Abstract Identifying subjects for clinical trials
is difﬁcult and the evidence base for
recruitment strategies is limited, particularly in
the ﬁeld of COPD. We compared the efﬁciency
and patient characteristics of different
community-based recruitment strategies during
a non-commercial COPD trial in the UK.
Recruiting from general practice COPD
registers was less efﬁcient and identiﬁed
patients with signiﬁcantly milder disease than
recruiting through pulmonary rehabilitation
and patient groups. We report our experience
and propose that pulmonary rehabilitation and
patient groups may represent an enriched pool
of COPD patients to recruit into clinical trials.
Trial registration number: EudraCT 2011-
001063-43
INTRODUCTION
Recruitment of patients into clinical trials
is challenging and many publicly funded
trials in the UK miss their targets.1 Many
studies investigating COPD may wish to
recruit from patient groups or primary
care; however, in contrast to the low rates
reported by recent large interventional
trials (eg, 7%2), evidence suggests that
patients on UK general practice (GP)
databases do not fulﬁl diagnostic criteria
for COPD when retested.3 Optimal strat-
egies for recruiting these patients have not
been adequately explored.
METHODS
Recruitment pathways
Three approaches were used during
recruitment of subjects to a recent non-
commercial trial of oral antibiotics in
stable COPD.
1. Local GP surgeries wrote to patients
on their COPD register, and interested
patients replied directly to the study
team using preaddressed reply slips.
2. Similarly, local pulmonary rehabilita-
tion (PR) groups wrote to COPD
patients on their database.
3. Study team members gave educational
talks to local PR and patient support
groups, and at the end described current
research plans. Interested patients
approached the study team directly.
Centres were reimbursed for sending
letters according to standard research tariffs.
Screening
Interested patients were contacted and a
screening visit arranged which included a
full medical history and postbronchodilator
spirometry. Patients were considered eligible
if COPD was conﬁrmed with FEV1 <80%
predicted and FEV1 to FVC ratio <0.7.
Analysis
The efﬁciency of identifying eligible
patients was assessed by comparing the
reply and screening failure rates. External
time and ﬁnancial costs were estimated
per eligible patient identiﬁed, excluding
researcher salaries. Patient characteristics
were compared by recruitment source.
RESULTS
Between January 2012 and May 2013, 37
GP surgeries and four PR groups sent
letters to 2300 and 469 patients, respect-
ively. Reply rates were similar from both
sources (21% and 22%) and 156 (7%) and
37 (8%) of these patients attended screen-
ing. The educational talks identiﬁed 53
patients, of whom 23 (43%) were screened.
Approaches 1 and 2 had screen failure rates
of 35% and 19%, while approach 3 had
the lowest (13%). Figure 1 summarises
these pathways and gives information on
the estimated time and ﬁnancial commit-
ments per eligible patient identiﬁed.
Eligible patients recruited from GP
surgeries had signiﬁcantly milder disease
than those from PR and patient groups
(mean (SD) FEV1 63% predicted (20) vs
53% (18, p=0.003), FEV1 to FVC ratio
0.55 (0.11) vs 0.50 (0.11, p=0.007),
exacerbations in the previous year 1.7 (2.0)
vs 2.7 (3.4, p=0.029)), as well as lesser
smoking history and fewer medication
Figure 1 Flow diagram detailing the three different recruitment pathways.
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prescriptions. Further information is
detailed in the online supplement.
DISCUSSION
We found that recruiting patients from GP
COPD databases was less efﬁcient, more
costly, and identiﬁed patients with milder
disease than through PR and patient
groups. However, the pool of patients
accessible via GPs was larger and more rep-
resentative of the wider population.
Recruitment via PR and patient groups may
therefore target an enriched population
useful for smaller studies, and researchers
planning future studies of COPD should
prioritise resources accordingly.
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